Nestle Skin Health draws private equity interest
The sale of Switzerland-based Nestle Skin Health has attracted considerable private equity interest, with first round of bids expected to value the business at $7bn (€6.1bn),
The sale of Switzerland-based Nestle Skin Health has attracted considerable private equity interest, with first round of bids expected to value the business at $7bn (€6.1bn),